| Fiscal Year End | Company Status | Exempt Flag |
| December 31 | Delist | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 31/Mar/2004 | 21/Apr/2014 | Canada | Alberta | |
|
|
| Exchange Filing Office |
| Location |
| (not available) |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| *Biotechnology Research &/or Development
| (not available)
|
|
| *Scientific Research And Development Services
| About Stem Cell Therapeutics (From News Release December 17, 2013)
Stem Cell Therapeutics Corp. (SCT) is an immuno-oncology company advancing cancer stem cell discoveries into novel and innovative cancer therapies. Building on over half a century of leading and groundbreaking Canadian stem cell research, the company is supported by established links to a group of prominent Toronto academic research institutes and cancer treatment centers, representing one of the world's most acclaimed cancer research hubs. The Company has two premier preclinical programs, SIRPaFc and a CD200 monoclonal antibody (mAb), which target two key immunoregulatory pathways that tumor cells exploit to evade the host immune system.
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| *SSS | *Stem Cell Therapeutics Corp. | TSX Venture | DELIST |
| *SSS | *Stem Cell Therapeutics Corp. old | TSX Venture | DELIST |
|
|
| Name History | From | To |
| *Stem Cell Therapeutics Corp. | 2/Dec/2004 | 21/Apr/2014 |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Summer 2013 CFR | 28/Mar/2014 |
|
|
|
|
|
